9-(2,3-dihydroxypropyl)adenine has been researched along with plerixafor in 1 studies
Studies (9-(2,3-dihydroxypropyl)adenine) | Trials (9-(2,3-dihydroxypropyl)adenine) | Recent Studies (post-2010) (9-(2,3-dihydroxypropyl)adenine) | Studies (plerixafor) | Trials (plerixafor) | Recent Studies (post-2010) (plerixafor) |
---|---|---|---|---|---|
56 | 0 | 10 | 1,312 | 113 | 930 |
Protein | Taxonomy | 9-(2,3-dihydroxypropyl)adenine (IC50) | plerixafor (IC50) |
---|---|---|---|
C-X-C chemokine receptor type 4 | Rattus norvegicus (Norway rat) | 0.108 | |
C-C chemokine receptor type 2 | Homo sapiens (human) | 0.0001 | |
C-X-C chemokine receptor type 4 | Homo sapiens (human) | 0.3717 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Clercq, E | 1 |
1 review(s) available for 9-(2,3-dihydroxypropyl)adenine and plerixafor
Article | Year |
---|---|
The discovery of antiviral agents: ten different compounds, ten different stories.
Topics: Acyclovir; Adenine; Antiviral Agents; Benzodiazepines; Benzylamines; Cidofovir; Cyclams; Cytosine; Heterocyclic Compounds; Humans; Imidazoles; Nucleosides; Organophosphonates; Tenofovir; Valacyclovir; Valine; Virus Diseases | 2008 |